Skip to main content

Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024

FOSTER CITY, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that members of senior management will be participating in a fireside chat at The Citizens JMP Life Sciences Conference 2024 on Tuesday, May 14, 2024 at 1:30 p.m. ET.

A live webcast of the fireside chat will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcast will be archived on Terns’ website for 30 days following the event.

About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist, and a preclinical GIPR modulator program. For more information, please visit: www.ternspharma.com.

Contacts for Terns

Investors
Justin Ng
investors@ternspharma.com 

Media
Jenna Urban
Berry & Company Public Relations
media@ternspharma.com 

 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.21
-4.82 (-2.17%)
AAPL  256.79
-5.98 (-2.28%)
AMD  228.27
-9.76 (-4.10%)
BAC  50.97
-0.55 (-1.07%)
GOOG  252.22
+0.88 (0.35%)
META  730.21
-3.06 (-0.42%)
MSFT  519.44
+1.78 (0.34%)
NVDA  178.79
-2.37 (-1.31%)
ORCL  273.81
-1.34 (-0.49%)
TSLA  435.80
-6.80 (-1.54%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.